A pilot study to compare dry cervical sample collection with standard practice of wet cervical samples for human papillomavirus testing

Journal of Clinical Virology

Volumn 69, Issue , 2015, Pages 210-213

  Sultana, Farhana ^a   Gertig, Dorota M ^a,b   Wrede, C David ^c   English, Dallas R ^a,d   Simpson, Julie A ^a   Drennan, Kelly T ^b   Brotherton, Julia M L ^a,e   Phillips, Gillian ^f   Heley, Stella ^f   Castle, Philip E ^g,h   Saville, Marion ^f  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Victorian Cervical Cytology Registry Melbourne   (Australia)

^c ROYAL WOMEN'S HOSPITAL   (Australia)

^d CANCER EPIDEMIOLOGY CENTRE   (Australia)

^e National HPV Vaccination Program Register   (Australia)

^f VCS FOUNDATION   (Australia)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^h Global Coalition Against Cervical Cancer   (United States)

Author keywords

Cervical sample; Dry swab; HPV testing; Randomised

Indexed keywords

VIRUS DNA;

ARTICLE; CANCER RISK; CANCER SCREENING; COLPOSCOPY; DRY CERVICAL SAMPLE; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PILOT STUDY; PRIORITY JOURNAL; SERODIAGNOSIS; UTERINE CERVIX CANCER; VIRUS DETECTION; WET CERVICAL SAMPLE; COMPARATIVE STUDY; GENETICS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; RANDOMIZATION; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX; VAGINA SMEAR; VIROLOGY;

CERVIX UTERI; FEMALE; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PILOT PROJECTS; RANDOM ALLOCATION; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; VAGINAL SMEARS;

EID: 84937945205     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2015.06.080     Document Type: Article

References (15)

1. IARC Working Group on the Evaluation of Cancer Preventive Strategies Cervix Cancer Screening, IARC Handbooks of Cancer Prevention 2005, vol. 10. IARC Press, Lyon.
2. Eperon I., Vassilakos P., Navarria I., Menoud P.A., Gauthier A., Pache J.C., Boulvain M., Untiet S., Petignat P. Randomized comparison of vaginal self-sampling by standard vs. dry swabs for Human papillomavirus testing. BMC Cancer 2013, 13:353.
3. Feng Q., Cherne S., Winer R.L., Popov V., Zambrano H., Yerovi C., Hawes S.E., Koutsky L.A., Kiviat N.B. Evaluation of transported dry and wet cervical exfoliated samples for detection of human papillomavirus infection. J. Clin. Microbiol. 2010, 48:3068-3072.
4. Shah K.V., Daniel R.W., Tennant M.K., Shah N., McKee K.T., Gaydos C.A., Gaydos J.C., Rompalo A. Diagnosis of human papillomavirus infection by dry vaginal swabs in military women. Sex. Transm. Infect. 2001, 77:260-264.
5. Wolfrum S.G., Koutsky L.A., Hughes J.P., Feng Q., Xi L.F., Shen Z., Winer R.L. Evaluation of dry and wet transport of at-home self-collected vaginal swabs for human papillomavirus testing. J. Med. Microbiol. 2012, 61:1538-1545.
6. Cerigo H., Coutlee F., Franco E.L., Brassard P. Dry self-sampling versus provider-sampling of cervicovaginal specimens for human papillomavirus detection in the Inuit population of Nunavik, Quebec. J. Med. Screening 2012, 19:42-48.
7. GmbH RD Cobas ® 4800HPV Test 2012, Roche Molecular Systems Inc.
8. Brotherton J.M., Fridman M., May C.L., Chappell G., Saville A.M., Gertig D.M. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 2011, 377:2085-2092.
9. Gertig D.M., Brotherton J.M., Budd A.C., Drennan K., Chappell G., Saville A.M. Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study. BMC Med. 2013, 11:227.
10. Krech T., Castriciano S., Jang D., Smieja M., Enders G., Chernesky M. Detection of high risk HPV and Chlamydia trachomatis in vaginal and cervical samples collected with flocked nylon and wrapped rayon dual swabs transported in dry tubes. J. Virol. Methods 2009, 162:291-293.
11. Arbyn M., Verdoodt F., Snijders P.J., Verhoef V.M., Suonio E., Dillner L., Minozzi S., Bellisario C., Banzi R., Zhao F.H., Hillemanns P., Anttila A. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol. 2014, 15:172-183.
12. Arrossi S., Thouyaret L., Herrero R., Campanera A., Magdaleno A., Cuberli M., Barletta P., Laudi R., Orellana L. Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial. Lancet Global Health 2015, 3:e85-e94.
13. Lazcano-Ponce E., Lorincz A.T., Cruz-Valdez A., Salmeron J., Uribe P., Velasco-Mondragon E., Nevarez P.H., Acosta R.D., Hernandez-Avila M. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet 2011, 378:1868-1873.
14. Sultana F., English D.R., Simpson J.A., Brotherton J.M., Drennan K., Mullins R., Heley S., Wrede C.D., Saville M., Gertig D.M. Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia. BMC Cancer 2014, 14:207.
15. Snijders P.J., Verhoef V.M., Arbyn M., Ogilvie G., Minozzi S., Banzi R., van Kemenade F.J., Heideman D.A., Meijer C.J. High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening. Int. J. Cancer 2013, 132:2223-2236. Journal International du Cancer.